KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Return on Capital Employed (2016 - 2025)

Regeneron Pharmaceuticals (REGN) has 14 years of Return on Capital Employed data on record, last reported at 0.11% in Q3 2025.

  • For Q3 2025, Return on Capital Employed changed N/A year-over-year to 0.11%; the TTM value through Sep 2025 reached 0.11%, changed N/A, while the annual FY2024 figure was 0.13%, 2.0% down from the prior year.
  • Return on Capital Employed reached 0.11% in Q3 2025 per REGN's latest filing, down from 0.11% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.22% in Q3 2022 and bottomed at 0.11% in Q3 2025.
  • Average Return on Capital Employed over 4 years is 0.15%, with a median of 0.15% recorded in 2023.
  • Peak YoY movement for Return on Capital Employed: dropped -7bps in 2023, then fell -2bps in 2024.
  • A 4-year view of Return on Capital Employed shows it stood at 0.19% in 2022, then fell by -26bps to 0.14% in 2023, then fell by -14bps to 0.12% in 2024, then dropped by -11bps to 0.11% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.11% in Q3 2025, 0.11% in Q2 2025, and 0.11% in Q1 2025.